为什么我们仍然没有针对恰加斯病的疫苗？
Why do we still have not a vaccine against Chagas disease?
机构信息
Universidade de São Paulo, São Paulo, SP, Brasil.
Fundação Oswaldo Cruz-Fiocruz, Rio de Janeiro, RJ, Brasil.
出版信息
Mem Inst Oswaldo Cruz. 2022 May 9;117:e200314. doi: 10.1590/0074-02760200314. eCollection 2022.
Abstract
This review does not intend to convey detailed experimental or bibliographic data. Instead, it expresses the informal authors' personal views on topics that range from basic research on antigens and experimental models for Trypanosoma cruzi infection to vaccine prospects and vaccine production. The review also includes general aspects of Chagas' disease control and international and national policies on the subject. The authors contributed equally to the paper.
摘要
这篇综述并不打算传达详细的实验或文献数据。相反，它表达了作者个人对从抗原的基础研究和克氏锥虫感染的实验模型到疫苗前景和疫苗生产等各个主题的非正式看法。综述还包括了查加斯病控制的一般方面以及该主题的国际和国家政策。作者对本文贡献均等。
相似文献
1
Why do we still have not a vaccine against Chagas disease?为什么我们仍然没有针对恰加斯病的疫苗？
Mem Inst Oswaldo Cruz. 2022 May 9;117:e200314. doi: 10.1590/0074-02760200314. eCollection 2022.
2
Vaccine development against Trypanosoma cruzi and Chagas disease.抗克氏锥虫和恰加斯病疫苗的研制。
Adv Parasitol. 2011;75:121-46. doi: 10.1016/B978-0-12-385863-4.00006-X.
3
Immunoprophylaxis against Chagas' disease.恰加斯病的免疫预防
Adv Exp Med Biol. 1977;93:243-80.
4
[Immune response to Trypanosoma cruzi. An approach to the pathogenesis of Chagas' disease].[对克氏锥虫的免疫反应。恰加斯病发病机制的一种研究方法]
Acta Physiol Pharmacol Latinoam. 1985;35(1):1-47.
5
Gene-deleted live-attenuated Trypanosoma cruzi parasites as vaccines to protect against Chagas disease.基因缺失的减毒活克氏锥虫寄生虫作为预防恰加斯病的疫苗。
Expert Rev Vaccines. 2015 May;14(5):681-97. doi: 10.1586/14760584.2015.989989. Epub 2014 Dec 11.
6
TcVac1 vaccine delivery by intradermal electroporation enhances vaccine induced immune protection against Trypanosoma cruzi infection in mice.皮内电穿孔递送 TcVac1 疫苗增强了疫苗诱导的对感染 Trypanosoma cruzi 的免疫保护作用。
Vaccine. 2019 Jan 7;37(2):248-257. doi: 10.1016/j.vaccine.2018.11.041. Epub 2018 Nov 27.
7
[Protection of mice with Trypanosoma lewisi antigen and its fractions against experimental Trypanosoma cruzi infection].[用杜氏利什曼原虫抗原及其组分对小鼠进行保护以抵抗实验性克氏锥虫感染]
Rev Inst Med Trop Sao Paulo. 1972 Sep-Oct;14(5):301-5.
8
Cruzipain and Its Physiological Inhibitor, Chagasin, as a DNA-Based Therapeutic Vaccine Against .克氏锥虫 cruzipain 及其生理抑制剂 chagasin 作为一种基于 DNA 的治疗性疫苗对抗.
Front Immunol. 2020 Oct 9;11:565142. doi: 10.3389/fimmu.2020.565142. eCollection 2020.
9
Previously unrecognized vaccine candidates control Trypanosoma cruzi infection and immunopathology in mice.先前未被识别的疫苗候选物可控制小鼠体内的克氏锥虫感染及免疫病理学。
Clin Vaccine Immunol. 2008 Aug;15(8):1158-64. doi: 10.1128/CVI.00144-08. Epub 2008 Jun 11.
10
Efficient protective immunity against Trypanosoma cruzi infection after nasal vaccination with recombinant Sendai virus vector expressing amastigote surface protein-2.用表达无鞭毛体表面蛋白-2的重组仙台病毒载体经鼻腔接种后对克氏锥虫感染产生高效保护性免疫。
Vaccine. 2009 Oct 19;27(44):6154-9. doi: 10.1016/j.vaccine.2009.08.026. Epub 2009 Aug 25.
引用本文的文献
1
The time has come for a vaccine against Chagas disease.是时候研发一种针对恰加斯病的疫苗了。
Lancet Reg Health Am. 2025 Mar 21;45:101059. doi: 10.1016/j.lana.2025.101059. eCollection 2025 May.
2
Fighting Strategies Against Chagas' Disease: A Review.对抗恰加斯病的斗争策略：综述
Pathogens. 2025 Feb 12;14(2):183. doi: 10.3390/pathogens14020183.
3
Human migrations, anthropogenic changes, and insect-borne diseases in Latin America.拉丁美洲的人类迁徙、人为变化与虫媒疾病
Parasit Vectors. 2025 Jan 9;18(1):4. doi: 10.1186/s13071-024-06598-7.
4
Influence of angiotensin II type 1 receptors and angiotensin-converting enzyme I/D gene polymorphisms on the progression of Chagas' heart disease in a Brazilian cohort: Impact of therapy on clinical outcomes.1型血管紧张素II受体和血管紧张素转换酶I/D基因多态性对巴西队列中恰加斯心脏病进展的影响：治疗对临床结局的影响。
PLoS Negl Trop Dis. 2024 Nov 26;18(11):e0012703. doi: 10.1371/journal.pntd.0012703. eCollection 2024 Nov.
5
Treatments and the Perspectives of Developing a Vaccine for Chagas Disease.恰加斯病的治疗方法及开发疫苗的前景
Vaccines (Basel). 2024 Aug 1;12(8):870. doi: 10.3390/vaccines12080870.
6
Adipocyte-released adipomes in Chagas cardiomyopathy: Impact on cardiac metabolic and immune regulation.恰加斯心肌病中脂肪细胞释放的脂肪因子：对心脏代谢和免疫调节的影响。
iScience. 2024 Apr 5;27(5):109672. doi: 10.1016/j.isci.2024.109672. eCollection 2024 May 17.
7
Harnessing RNA Technology to Advance Therapeutic Vaccine Antigens against Chagas Disease.利用 RNA 技术推进抗恰加斯病治疗性疫苗抗原。
ACS Appl Mater Interfaces. 2024 Apr 3;16(13):15832-15846. doi: 10.1021/acsami.3c18830. Epub 2024 Mar 22.
8
Nanotechnology-Based Strategies in Parasitic Disease Management: From Prevention to Diagnosis and Treatment.基于纳米技术的寄生虫病管理策略：从预防到诊断与治疗
ACS Omega. 2023 Nov 1;8(45):42014-42027. doi: 10.1021/acsomega.3c04587. eCollection 2023 Nov 14.
9
Anxiety, depression, and memory loss in Chagas disease: a puzzle far beyond neuroinflammation to be unpicked and solved.恰加斯病中的焦虑、抑郁和记忆丧失：一个远非神经炎症那么简单的谜题，有待我们去解开。
Mem Inst Oswaldo Cruz. 2023 Apr 3;118:e220287. doi: 10.1590/0074-02760220287. eCollection 2023.
10
A Review on the Immunological Response against .关于针对……的免疫反应的综述
Pathogens. 2023 Feb 8;12(2):282. doi: 10.3390/pathogens12020282.
本文引用的文献
1
Immunity and vaccine development efforts against Trypanosoma cruzi.针对克氏锥虫的免疫和疫苗开发工作。
Acta Trop. 2019 Dec;200:105168. doi: 10.1016/j.actatropica.2019.105168. Epub 2019 Sep 9.
2
Revisiting the concept of Innovative Developing Countries (IDCs) for its relevance to health innovation and neglected tropical diseases and for the prevention and control of epidemics.重新审视创新发展中国家（IDCs）的概念，探讨其与卫生创新和被忽视热带病的相关性，以及对传染病的预防和控制的意义。
PLoS Negl Trop Dis. 2018 Jul 12;12(7):e0006469. doi: 10.1371/journal.pntd.0006469. eCollection 2018 Jul.
3
Status of vaccine research and development of vaccines for Chagas disease.恰加斯病疫苗的研发现状
Vaccine. 2016 Jun 3;34(26):2996-3000. doi: 10.1016/j.vaccine.2016.03.074. Epub 2016 Mar 26.
4
A human type 5 adenovirus-based Trypanosoma cruzi therapeutic vaccine re-programs immune response and reverses chronic cardiomyopathy.一种基于人5型腺病毒的克氏锥虫治疗性疫苗可重新编程免疫反应并逆转慢性心肌病。
PLoS Pathog. 2015 Jan 24;11(1):e1004594. doi: 10.1371/journal.ppat.1004594. eCollection 2015 Jan.
5
The main sceneries of Chagas disease transmission. The vectors, blood and oral transmissions--a comprehensive review.恰加斯病传播的主要情况。媒介传播、血液传播和经口传播——全面综述。
Mem Inst Oswaldo Cruz. 2015 May;110(3):277-82. doi: 10.1590/0074-0276140362. Epub 2014 Dec 2.
6
The revised Trypanosoma cruzi subspecific nomenclature: rationale, epidemiological relevance and research applications.修订后的克氏锥虫亚种命名法：原理、流行病学相关性和研究应用。
Infect Genet Evol. 2012 Mar;12(2):240-53. doi: 10.1016/j.meegid.2011.12.009. Epub 2011 Dec 27.
7
Advances and challenges towards a vaccine against Chagas disease.抗恰加斯病疫苗的进展与挑战
Hum Vaccin. 2011 Nov;7(11):1184-91. doi: 10.4161/hv.7.11.17016. Epub 2011 Nov 1.
8
Testing the efficacy of a multi-component DNA-prime/DNA-boost vaccine against Trypanosoma cruzi infection in dogs.检测一种多组分 DNA-prime/DNA-boost 疫苗对感染克氏锥虫的犬的疗效。
PLoS Negl Trop Dis. 2011;5(5):e1050. doi: 10.1371/journal.pntd.0001050. Epub 2011 May 17.
9
Co-administration of a plasmid DNA encoding IL-15 improves long-term protection of a genetic vaccine against Trypanosoma cruzi.共给药编码白细胞介素-15 的质粒 DNA 可改善针对克氏锥虫的基因疫苗的长期保护作用。
PLoS Negl Trop Dis. 2011 Mar 8;5(3):e983. doi: 10.1371/journal.pntd.0000983.
10
The endless race between Trypanosoma cruzi and host immunity: lessons for and beyond Chagas disease.克氏锥虫与宿主免疫之间的无尽竞赛：恰加斯病的教训及其他。
Expert Rev Mol Med. 2010 Sep 15;12:e29. doi: 10.1017/S1462399410001560.
Zotero 插件